News
Latest news related to non-animal research
-
17 June 2025NAMs : a ‘Complement’ to animal experimentation?, IHB New Co-Director for computational biology, Preclinical : Vivodyne replaces animal testing, A Bioprinted 3D lung model and more
NEWS, REPORTS & POSITION STATEMENTS 1. 3rd European Commission workshop to establish its roadmap for the phasing out of animal testing On 16 – 17 June 2025, the European Commission (EC), in collaboration with ECHA, organised a third workshop to discuss the […]
Read more -
11 June 2025Organoid biobanks, Shaping Standards for the MPS, Two global partnerships : InSphero x Tessara Therapeutics & Merck x imec, Stanford breakthrough in vascularized organoids and more
NEWS, REPORTS & POSITION STATEMENTS 1. Organoid biobanks : a breakthrough — but for whom ? Organoids are reshaping biomedical research and drug development by offering more physiologically relevant models. But one critical issue is often overlooked : the lack of population diversity in organoid biobanks. […]
Read more -
4 June 2025European Research Area policy agenda, Regulatory risk decision-making, Frameworks for integrating NAMs, Human OoC and more
NEWS, REPORTS & POSITION STATEMENTS 1. European research area policy agenda for the next three years The Council has reached a political agreement on a council recommendation to adopt the European Research Area (ERA) Policy Agenda 2025 – 2027. The ERA policy agenda […]
Read more -
28 May 2025Winners of the German Startup Awards and MEET2WIN, A GPT Agent for OoC, Mapping the future of organoids, SARA-ICE : Skin Sensitization Risk Assessment and more
NEWS, REPORTS & POSITION STATEMENTS 1. FDA’s shift from animal testing opens doors for organoid makers The FDA says that over the next 3 – 5 years it aims “to make animal studies the exception rather than the norm” for preclinical safety […]
Read more -
20 May 2025New risk assessment strategies with NAM, The NAM Navigator, 3D Bone Marrow Niche In Vitro Models, Digitalized organoids and more
NEWS, REPORTS & POSITION STATEMENTS 1. Infant with rare, incurable disease is first to successfully receive personalized gene therapy treatment In a groundbreaking advance for individualized medicine, an infant diagnosed with carbamoyl phosphate synthetase 1 (CPS1) deficiency— a rare and […]
Read more
